期刊文献+

伽玛刀放射外科治疗垂体腺瘤的疗效评价 被引量:3

Evaluation on gamma knife radiosurgery in treatment of pituitary adenomas
下载PDF
导出
摘要 目的评价伽玛刀(Gamma Knife)放射外科治疗垂体腺瘤的疗效及安全性。方法对2010年1月~2013年12月期间采用OUR旋转式伽玛刀作为首选方法治疗的143例垂体腺瘤患者的临床资料进行回顾性研究,PRL型54例、GH型24例、ACTH型11例、混合型(GH+PPL)15例和无功能型(NFA)39例。肿瘤直径2 mm^64 mm(平均26.3 mm),30%~70%等剂量曲线包绕肿瘤,肿瘤平均周边剂量26.5Gy,平均中心剂量41.0Gy。对术后随访患者的临床症状、血液激素水平和鞍区MRI检查结果进行对比分析。结果随访期3~30个月,平均18月,临床症状改善或消失103例(72.0%),激素水平下降或恢复正常84例(80.8%),肿瘤缩小或消失87例(60.8%),平均肿瘤生长控制率为95.1%。结论伽玛刀放射外科对各种类型垂体腺瘤的治疗是安全有效的,能够改善和控制大部分患者的临床症状、激素水平和肿瘤生长。 Objective To evaluate the effectiveness and complications of gamma knife surgery for treating pituitary adenomas.Methods The clinical data of 143 patients with pituitary adenomas were performed by the gamma knife in our center from January 2010 to December 2013 were analyzed retrospectively.There were 54 prolactin secreting adenomas ( PRL), 24 growth hormone secreting adenomas ( GH ) , 11 adrenocorticotrophic hormone secreting adenomas ( ACTH ) , 15 prolactin/growth secreting hormone ( PRL/GH ) adenomas and 39 non-functional adenomas. Average maximum tumor diameter was 26.3mm (2 ~64mm).The average does in the center of tumor was 41.0Gy and the average does was 26.5Gy with 30%~70%isodoes line.Results 143 patients were followed up with an average follow-up period of 18 months (3~30 months) .Clinical symptoms of 103 ( 72.0%) patients were released or disappeared.Improved endocrine status occurred in 84 cases(80.8%).87(60.8%) patients experienced arrest of tumor growth.Average control rate was 95.1%.Conclusion Gamma knife radiosurgery is a safe and effective therapeutic method of achieving clinical symptoms control, endocrine remission/stability and tumor growth control in pituitary adenomas.
出处 《临床神经外科杂志》 CAS 2014年第6期419-422,共4页 Journal of Clinical Neurosurgery
基金 教育部新世纪优秀人才支持计划资助项目(No.NCET-05-0831)
关键词 伽玛刀 垂体腺瘤 疗效 回顾性研究 gamma knife pituitary adenoma curative effect retrospective study
  • 相关文献

参考文献10

  • 1Aflorei ED, Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas [ J ]. Neuro-Oncology, 2014,117 : 379.
  • 2张风林,应奇,高苏慧,骆纯,丁学华.亚临床型垂体腺瘤卒中的诊治[J].临床神经外科杂志,2013,10(4):221-223. 被引量:3
  • 3马驰原,王汉东,史继新,杭春华,樊友武,孙康健,潘云曦,文立利,王友伟.垂体瘤术后残留短期内再次手术治疗:联合与分期[J].临床神经外科杂志,2011,8(6):298-300. 被引量:11
  • 4Sun DQ, Cheng JJ, Frazier JL, et al. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature [ J ]. Neurosurgical Review, 2011,34:181.
  • 5梁恩顺,佘永传,朱海东.两种伽玛刀剂量区间治疗功能性垂体腺瘤对比研究[J].临床神经外科杂志,2012,9(1):24-26. 被引量:3
  • 6Kajiwara K, Saito KI, Yoshikawa K, et al. Stereotactic radio- surgery/radiotherapy for pituitary adenomas: A review of recent literature[ J]. Neurologia Medico-Chirurgica ,2010,50:749.
  • 7Ganz JC. Gamma-knife treatment of pituitary-adenomas [ J ]. Stereotactic Functional Neurosurgery, 1995,64:3.
  • 8Jagannathan J, Yen C-P, Pouratian N, et ol. Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife [ J ]. Neuro-Oncology, 2009,92 : 345.
  • 9Gopalan R, Schlesinger D, Vance ML, et al. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma[J]. Neurosurgery,2011,69 :284.
  • 10Pouratian N, Sheehan J, Jahannathan J, et al. Gamma knife radiosurgery for medically and surgically refractory prolactinomas [ J]. Neurosurgery, 2006,59:255.

二级参考文献27

  • 1马驰原,史继新.垂体腺瘤的术前影像学预判[J].中国医学影像技术,2005,21(4):649-652. 被引量:2
  • 2赵元立,于书卿,王嵘,赵继宗.垂体大腺瘤的神经导航经蝶手术治疗[J].中华神经外科疾病研究杂志,2005,4(5):406-410. 被引量:1
  • 3Frederic Castinetti, Mariko Nagai, Isabelle Morange, et al. Long- term results of stereotactic radiosurgery in secretory pituitary adenomas[ J]. J Clin Endocrinol Metab,2009,94:3400.
  • 4Vladyka V, Liscak R, Novotny J. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas[ J]. Neurosurgery, 2003,52 : 09.
  • 5Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas[ J]. Clin Endocrinol (Oxf) ,2006,65:265.
  • 6Vladyka V, Liscak R, Novotny J Jr, et al. Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas [ J ]. Neurosurgery, 2003,52 : 309.
  • 7Pan L,Zhang N, Wang EM, et al. Gamma knife radiosurgery as a primary treatment for prolaetinomas[ J]. J Neurosurg,2000,93 : 10.
  • 8Ikeda H, Jokura H, Yoshimoto T. Gamma knife radiosurgery for pituitary adenomas: usefulness of combined transsphenoidal an d gamma knife radiosurgery for adenomas invading the cavernous sinus[ J ]. Radiat Oncol havestig, 1998,6:26.
  • 9Ganz JC, Backlund EO, Thorsen FA, et al. The effects of gamma knife surgery of pituitary adenomas on tumor growth and endocrinopathies[ J]. Stereotact Funct Neurosurg, 1993,61:30.
  • 10马廉亭.微侵袭神经外科学[M].北京:人民军医出版社,1995.305-312.

共引文献12

同被引文献55

  • 1Merrell RT,Anderson SK,Meyer FB,et al.Seizures in patients with glioma treated with phenytoin and levetiracetam[J].J Neurosurg,2010,113:1176.
  • 2Maschio M,Dinapoli L,Mingoia al.Lacosamide as add-on in brain tumor-related epilepsy:preliminary report on efficacy and tolerability[J].J Neurol,2011,258:2100.
  • 3Vecht CJ,Wilms EB.Seizures in low-and high-grade gliomas:current management and future outlook[J].Expert Rev Anticancer Ther,2010,10:663.
  • 4Butowski NA,Chang SM.General and neurological complications of targeted therapy.In:Grisold W,Soffietti R,editors.Handbook of clinical neurology[M].Edinburgh:Elsevier,2012:937.
  • 5Bauer B,Hartz AM,Pekcec A,ei al.Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling[J].Mol Pharmacol,2008,73:1444.
  • 6Phi JH,Kim SK,Cho BK,e? al.Long-term surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors[J].Cancer,2009,115:5771.
  • 7Maschio M,Dinapoli L,Mingoia M,et al.Lacosamide as add-on in brain tumor-related epilepsy:preliminary report on efficacy and tolerability[J].J Neurol,2011,258:2100.
  • 8Bello L,Fava E,Carrabba G,et al.Present day's standards in microsurgery of low-grade gliomas[J].Adv Tech Stand Neurosurg,2010,35:113.
  • 9Yordanova YN,Moritz-Gasser S,Duffau H.Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere:toward a "supratotal" resection.Clinical article[J].J Neurosurg,2011,115:232.
  • 10Yang I,Chang EF,Han SJ,et al.Early surgical intervention in adult patients with ganglioglioma is associated with improved clinical seizure outcomes[J].J Clin Neurosci,2011,18:29.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部